Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Autoimmunity Biologic Solutions, Inc. in May, 2020 for $283,667.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AI149920-01 | Phase I | 283,667 | May 5, 2020 | |||||||
A SBIR Phase I contract was awarded to Autoimmunity Biologic Solutions, Inc. in September, 2021 for $324,675.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA257108-01A1 | Phase I | 324,675 | September 1, 2021 | |||||||
A STTR Phase II contract was awarded to Autoimmunity Biologic Solutions, Inc. in August, 2022 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42AI141323-02A1 | Phase II | 1,000,000 | August 22, 2022 | |||||||
A SBIR Phase I contract was awarded to Autoimmunity Biologic Solutions, Inc. in April, 2019 for $170,266.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI143319-01 | Phase I | 170,266 | April 4, 2019 | |||||||
A STTR Phase I contract was awarded to Autoimmunity Biologic Solutions, Inc. in January, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AI141323-01A1 | Phase I | 225,000 | January 22, 2019 | |||||||
A SBIR Phase I contract was awarded to Autoimmunity Biologic Solutions, Inc. in August, 2022 for $306,500.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI172660-01 | Phase I | 306,500 | August 17, 2022 |